研究文章
术前注射维生素D3的临床效用总甲状腺切除术后预防瞬态低钙血症
表3
比较的基线之间的瞬态低钙血症患者临床病理的特点注射维生素D3 (VDI)和维生素D3 noninjection (VDN)组。
|
|
VDI (n= 67) |
VDN (n= 571) |
价值 |
|
| 年龄(年) |
46.1±14.1(范围,16 - 78) |
45.0±13.7(范围、8 - 84) |
0.538 |
| 女 |
54 (80.6%) |
460例(80.6%) |
0.967 |
| Multifocality |
42 (62.7%) |
331例(58.0%) |
0.513 |
| 两侧对称 |
31 (46.3%) |
266例(46.6%) |
0.961 |
| 研讨会 |
18 (26.9%) |
97例(17.0%) |
0.063 |
| 操作时间(分钟) |
176.7±210.3(范围,48 - 490) |
150.7±70.4(范围、50 - 635) |
0.034 |
| 住院时间(天) |
4.1±1.2(范围3 - 7) |
2-23 3.9±1.5(范围) |
0.315 |
| 肿瘤大小(cm) |
1.4±1.2(范围0.2 - -6.3) |
1.3±0.9(范围0.2 - -10.5) |
0.404 |
|
| T台 |
|
|
0.135 |
| T1 |
43 (64.2%) |
424例(74.3%) |
|
| T2 |
6 (8.9%) |
46 (8.0%) |
|
| T3 |
3 (4.5%) |
34 (6.0%) |
|
| T4a |
15 (22.4%) |
65例(11.4%) |
|
| T4b |
0 (0%) |
1 (0.2%) |
|
|
| N阶段 |
|
|
0.129 |
| N0 |
23 (34.3%) |
192例(33.6%) |
|
| N1a |
16 (23.9%) |
199例(34.9%) |
|
| N1b |
28 (41.8%) |
180例(31.5%) |
|
|
| M阶段 |
|
|
0.028 |
| M1 |
3 (4.5%) |
4 (0.7%) |
|
|
| TNM阶段 |
|
|
0.608 |
| 阶段我 |
51 (76.1%) |
475例(83.2%) |
|
| 第二阶段 |
13 (19.4%) |
78例(16.7%) |
|
| 第三阶段 |
3 (4.5%) |
15 (2.6%) |
|
| IVa期 |
0 (0%) |
1 (0.2%) |
|
| 阶段IVb |
0 (0%) |
1 (0.2%) |
|
|
|
数据表示为病人的数目(%),或平均数±标准差。定义为统计上的显著差异 < 0.05。于高频,extrathyroidal扩展;T,肿瘤;N,节点;米,转移。
|
